Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Augustin

Showing results (441-450 of 491) with videos related to

Pageof 50
Sort By:
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
International Journal of Dermatology|July 4, 2024
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statementPavel Viktorovich Chernyshov, Lucia Tomas-Aragones, Torsten Zuberbier, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 7, 2016
Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcersRobert S Kirsner, Wolfgang Vanscheidt, David H Keast, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Allergy|May 20, 2026
Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 SusceptibilityPhila Cara Baumann, Rebecca Pospich, Katinka Döhner, et al.
Acta Dermato-Venereologica|March 13, 2025
Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?Svenja Müller, Claudia Zeidler, Christian Mess, et al.
Expert Review of Clinical Immunology|April 26, 2021
Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29<sup>th</sup> EADV virtual congress, 29-31 October 2020Ulrich Mrowietz, Peter Van De Kerkhof, Andreu Schoenenberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2018
Praxis der TeledermatologieMatthias Augustin, Johannes Wimmer, Tilo Biedermann, et al.
Pageof 50

Showing results (441-450 of 491) with videos related to

Sort By:
Pageof 50
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|August 23, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 1Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
International Journal of Dermatology|July 4, 2024
Quality of life measurement in assessing treatment effectiveness in urticaria: European experts position statementPavel Viktorovich Chernyshov, Lucia Tomas-Aragones, Torsten Zuberbier, et al.
Wound Repair and Regeneration : Official Publication of the Wound Healing Society [And] the European Tissue Repair Society|August 7, 2016
Phase 3 evaluation of HP802-247 in the treatment of chronic venous leg ulcersRobert S Kirsner, Wolfgang Vanscheidt, David H Keast, et al.
Psoriasis (Auckland, N.Z.)|July 3, 2025
Patient-Reported Well-Being in Value-Based Routine Care Using Tildrakizumab: 52-week Interim Data of the Phase IV Positive StudyUlrich Mrowietz, Rachel Sommer, Sascha Gerdes, et al.
Psoriasis (Auckland, N.Z.)|May 18, 2026
Patient-Reported Well-Being in Value-Based Routine Care in Psoriatic Disease Using Tildrakizumab: 2-Year Data of the Phase IV POSITIVE StudyUlrich Mrowietz, Rachel Sommer, Ziad Reguiai, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|September 21, 2019
S2k guidelines for the treatment of psoriasis in children and adolescents - Short version part 2Lisa Eisert, Matthias Augustin, Sabine Bach, et al.
Allergy|May 20, 2026
Keratinocyte Priming by Staphylococcus aureus Reduces HSV-1 SusceptibilityPhila Cara Baumann, Rebecca Pospich, Katinka Döhner, et al.
Acta Dermato-Venereologica|March 13, 2025
Patient Needs and Treatment Goals in Chronic Atopic Pruritus: Does Eczema Make a Difference?Svenja Müller, Claudia Zeidler, Christian Mess, et al.
Expert Review of Clinical Immunology|April 26, 2021
Efficacy of dimethyl fumarate treatment for moderate-to-severe plaque psoriasis: presentation extracts from the 29<sup>th</sup> EADV virtual congress, 29-31 October 2020Ulrich Mrowietz, Peter Van De Kerkhof, Andreu Schoenenberger, et al.
Journal Der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG|July 13, 2018
Praxis der TeledermatologieMatthias Augustin, Johannes Wimmer, Tilo Biedermann, et al.
Pageof 50